Company intelligence / Profile preview

Ice-America

Reggio Emilia, Emilia-Romagna, Italyice-america.com ↗

Ownership: Private
Employees: ~1500
Development stage: Commercial

Overview

ICE Pharma is a leading global producer of bile acid derivatives, especially Ursodeoxycholic Acid (UDCA), with an integrated manufacturing network serving over 50 countries. They offer APIs, finished dosage forms, excipients, and new chemical entities focused on liver health and related indications.

Therapeutic areas: Gastroenterology
Modalities: Small molecule (bile acid derivatives, Ursodeoxycholic acid)
Industry: Biotech

Beyond the preview

Go deeper on Ice-America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ice-America.

Explore the full profile